Jim Cramer Likes These 5 Stocks

2. AbbVie Inc. (NYSE:ABBV)

Earlier this month, Jim Cramer said that AbbVie (NYSE:ABBV) is “still cheap” and he recommended his viewers to stay long Abbvie. Cramer said that his investing club has a “large” position in the company. Cramer also likes that company’s dividend.

AbbVie is a dividend aristocrat with over 25 years of dividend growth. In the fourth quarter, AbbVie’s revenue jumped 7% on a year-over-year basis to reach $14.9 billion. In 2022, the company expects adjusted EPS to come in at $14.00 to $14.20.

AbbVie is also a very popular stock among elite hedge funds. 82 hedge funds in our database entered 2022 with AbbVie in their portfolios. The total worth of stakes owned by these funds in the biotech company is $3.7 billion.